GLP-1 treatments are projected to lead to an annual revenue reduction of $30$55 billion by 20302034 for the food and beverage industry, with consumers taking in 21% fewer calories and spending 31% less on groceries, said Lucas Ferreira, who covers Latin America Food, Beverages and Agribusiness at J.P
Possible Concerns of Weight-Loss Drugs When GLP-1 agonists first came out, there was an association with increased risk of thyroid cancer
Our research will translate these insights into tools and approaches that improve access to obesity care
Se presenta en un envase de 30 cpsulas vegetales
So youd still need to be motivated to eat that food and then that food needs to be really attractive and it needs to be accessible. While a satiety-promoting diet can be successful, Columbia Universitys Zuraikat explains, this may be offset by certain adaptations
10.1016/j.copbio.2011.11.014 510 SakiyamaY.MazurA.KapinosL